Beam Therapeutics launched to develop Harvard base editing technology toward precision genetic medicines – Harvard Office of Technology Development
Harvard Office of Technology Development |
Beam Therapeutics launched to develop Harvard base editing technology toward precision genetic medicines
Harvard Office of Technology Development Genome editing technologies using the CRISPR platform in combination with enzymes like Cas9 and Cpf1 have shown great promise for adjusting genes through insertions or deletions of multiple nucleotides, but have had more difficulty correcting single … Beam Therapeutics Founded by Gene Editing Pioneers to Create Precision Genetic Medicines with Base Editing |
